Hematuria pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Adnan Ezici (talk | contribs) No edit summary |
Adnan Ezici (talk | contribs) No edit summary |
||
| Line 62: | Line 62: | ||
*On gross pathology, | *On gross pathology, | ||
**Multiple cyst formation and kidney enlargement are characteristic findings of autosomal dominant polycystic kidney disease (ADPKD)<ref name="pmid30422529">{{cite journal |vauthors=Akbar S, Bokhari SRA |title= |journal= |volume= |issue= |pages= |date= |pmid=30422529 |doi= |url=}}</ref> | **Multiple cyst formation and kidney enlargement are characteristic findings of autosomal dominant polycystic kidney disease (ADPKD)<ref name="pmid30422529">{{cite journal |vauthors=Akbar S, Bokhari SRA |title= |journal= |volume= |issue= |pages= |date= |pmid=30422529 |doi= |url=}}</ref> | ||
[[File:Polycystic Kidney.jpg|thumb| | [[File:Polycystic Kidney.jpg|thumb|center|Polycystic kidney disease, gross pathology (By Ed Uthman from Houston, TX, USA - Adult Polycystic Kidney, CC BY 2.0, https://commons.wikimedia.org/w/index.php?curid=3062826)]] | ||
**Solid yellow/golden lesions (because of the cells with lipid-rich cytoplasma), internal necrosis, cystic degeneration, and hemorrhage are characteristic findings of clear cell renal cell carcinoma | **Solid yellow/golden lesions (because of the cells with lipid-rich cytoplasma), internal necrosis, cystic degeneration, and hemorrhage are characteristic findings of clear cell renal cell carcinoma | ||
[[File:Renal cell carcinoma.jpg|thumb| | [[File:Renal cell carcinoma.jpg|thumb|center|Clear cell renal cell carcinoma (By Ed Uthman, MD (1953– ) - http://web2.airmail.net/uthman/specimens/images/renal_cell_ca.html, Public Domain, https://commons.wikimedia.org/w/index.php?curid=841054)]] | ||
==Microscopic Pathology== | ==Microscopic Pathology== | ||
Revision as of 14:44, 20 July 2021
|
Hematuria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hematuria pathophysiology On the Web |
|
American Roentgen Ray Society Images of Hematuria pathophysiology |
|
Risk calculators and risk factors for Hematuria pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
It is understood that glomerular hematuria is caused by either the dysfunction or damage of the glomerular filtration barrier(GFB).
Pathophysiology
Pathogenesis
It is understood that glomerular hematuria is caused by either the dysfunction or damage of the glomerular filtration barrier(GFB).[1]
- Major components of GFB include:
- Endothelial surface layer (composed of glycosaminoglycans)
- Endothelial cells
- Glomerular basement membrane (GBM)
- Slit diaphragms
- Subpodocyte space
The pathophysiologic mechanism of glomerular hematuria might be further classified into 6 subtype depending on the primary and histopathologic localization.[1]
- Injuries of the glomerular endothelial cell and surface layer
- Primary and secondary GBM disorders
- Diseases that can cause mesangial deposition
- Diseases that can cause subendothelial and subepithelial deposition
- Podocyte-associated disorders
- Miscellaneous
Genetics
Molecular defects involved in the pathogenesis of glomerular hematuria include:[1]
Diseases with structural GBM damage
- In the pathogenesis of alport syndrome:
- COL4A5 (X linked)
- COL4A3/COL4A4 (autosomal recessive)
- In the pathogenesis of thin basement membrane disease:
- COL4A3/COL4A4
- In the pathogenesis of hereditary angiopathy, nephropathy, aneurysms, and muscle cramps syndrome:
- COL4A1
Diseases with structural podocyte damage
- In the pathogenesis of MYH9-related disorder:
- Non muscle myosin IIA heavy chain
Storage disorders
- In the pathogenesis of fibronectin glomerulonephritis:
- Fibronectin
- In the pathogenesis of fibrillary glomerulonephritis:
- 10-30 nm fibrils
- In the pathogenesis of fabry’s disease:
- lysosomal storage
- In the pathogenesis of immunotactoid glomerulonephritis:
- Fibrils that are > 30 nm
Autoimmune disorders
- In the pathogenesis of ANCA (antineutrophil cytoplasmic antibodies):
- Antibodies against endothelium
- In the pathogenesis of anti-GBM:
- Antibodies against COL4
Complement mediated disorders
- In the pathogenesis of C3 glomerulopathy:
- Alternative pathway
Infectious (endocapillary) diseases
- In the pathogenesis of IgA nephritis:
- Galactose-deficient IgA1
Gross Pathology
Gross pathology might differ depending on the underlying etiology of hematuria.
- On gross pathology,
- Multiple cyst formation and kidney enlargement are characteristic findings of autosomal dominant polycystic kidney disease (ADPKD)[2]
- Solid yellow/golden lesions (because of the cells with lipid-rich cytoplasma), internal necrosis, cystic degeneration, and hemorrhage are characteristic findings of clear cell renal cell carcinoma
Microscopic Pathology
Microscopic pathology might differ depending on the underlying etiology of hematuria.
- On microscopic histopathological analysis,
- Diffuse thinning of the glomerular basement membrane (GBM) is characteristic finding of thin basal membrane disease[3]
- Lobular appearance with massive fibronectin deposits and the absence of immunoglobulin/complement deposition are characteristic findings of fibronectin nephropathy[4]
- Randomly aligned fibrillar deposits that measure 12-24 nm is characteristic finding of fibrillary nephropathy[5][6]
References
- ↑ 1.0 1.1 1.2 Yuste C, Gutierrez E, Sevillano AM, Rubio-Navarro A, Amaro-Villalobos JM, Ortiz A, Egido J, Praga M, Moreno JA (May 2015). "Pathogenesis of glomerular haematuria". World J Nephrol. 4 (2): 185–95. doi:10.5527/wjn.v4.i2.185. PMC 4419128. PMID 25949932.
- ↑ Akbar S, Bokhari S. PMID 30422529. Vancouver style error: initials (help); Missing or empty
|title=(help) - ↑ Foster K, Markowitz GS, D'Agati VD (May 2005). "Pathology of thin basement membrane nephropathy". Semin Nephrol. 25 (3): 149–58. doi:10.1016/j.semnephrol.2005.01.006. PMID 15880325.
- ↑ Lusco MA, Chen YP, Cheng H, Dong HR, Najafian B, Alpers CE, Fogo AB (November 2017). "AJKD Atlas of Renal Pathology: Fibronectin Glomerulopathy". Am J Kidney Dis. 70 (5): e21–e22. doi:10.1053/j.ajkd.2017.09.001. PMID 29055354.
- ↑ Klomjit, Nattawat; Alexander, Mariam Priya; Zand, Ladan (2020). "Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9)". Kidney360. 1 (9): 1002–1013. doi:10.34067/KID.0002532020. ISSN 2641-7650.
- ↑ Rosenstock JL, Markowitz GS (July 2019). "Fibrillary Glomerulonephritis: An Update". Kidney Int Rep. 4 (7): 917–922. doi:10.1016/j.ekir.2019.04.013. PMC 6611949 Check
|pmc=value (help). PMID 31317113.